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ABSTRACT 
 
Aims: Glutamate cysteine ligase (GCL) enzyme is involved in the synthesis of glutathione, which functions as an 
antioxidant. Polymorphisms in the sequence of amino acids making up the gene GCLC will cause differences in enzyme 
expression and GCLC activity. Gene expression that is influenced by oxidative stress can be used to measure markers 
such as F2-isoprostanes. This study aims to examine the association between the polymorphism in the GCLC gene with 
glutathione plasma level and F2-isoprostanes in contacts of person with infectious tuberculosis (TB). 
Methodology and results: Samples are taken from the family members of pulmonary TB patients who seeks treatment 
at the Pulmonary Centre (Lung Health Center for Public = BBKPM) and Policlinic of Dr Wahidin Sudirohusodo Hospital, 
Makassar. Total of approximately  4 mL of venous blood are taken from each person with pulmonary TB contacts and 
furtherly analyzed using genomic PCR-RFLP method and ELISA. Our results described that contacts of person with 
infectious TB for approximately 6 months have polymorphism C/C genotype at 80.3%, C/T of 18.3% and T/T for 1.4% of 
the total 71 samples with high levels of glutathione from 0.167 to 0.548 mM/mL and F2-isoprostanes level 72.4 - 1343.9 
pg/mL. 
Conclusion, significance and impact of study: There are no significant association between GCLC gene 
polymorphism with glutathione and F2-isoprostanes levels of individual who had contacted infection TB. In this study the 
elevation of F2-isoprostanes equal to the decrease levels of glutathione.  
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INTRODUCTION 
 
 
Currently, pulmonary tuberculosis (TB) is not merely 
described as an acute infectious disease but widespread 
in chronic infectious diseases, given the occurrence of 
several cases of anti-tuberculosis drug resistance in 
patients with TB, known as MDR / Multidrug resistance 
(resistance to several kinds of anti-tuberculosis drug). 
Some researchers reported that administration of the anti-
tuberculosis drug in patients with suspected TB yields a 
wide range of Reactive Oxygen Species / ROS (free 
radicals). Elevated ROS level can cause oxidative stress 
(Chowdhury et al., 2001; Wiid et al., 2004; Tostmann et 
al., 2007). TB oxidative stress is a state of the redox 
imbalance between oxidants and antioxidants in the lungs. 
Oxidative stress are measured by assessing the 
biochemical marker such as malondialdehyde (MDA), 
oxidized low-density lipoprotein (Ox-LDL) and F2-
isoprostanes (Milne et al., 2011). F2-isoprostanes is a 
product of lipid peroxidation formed by non-enzymatic and 
can be measured in blood, urine or tissue (Montuschi et 
al., 2004). Lipid peroxidation is an oxidative  damage to 
lipid biomolecule by ROS. F2-isoprostanes is currently 
regarded as a  reliable biomarker of oxidative stress in 
vivo due to its stability and high specificity, and how it is 
conveniently measured  (Janicka et al., 2010; Milne et al., 
2011). 
The defense mechanism of host body against 
infection of Mycobacterium tuberculosis (MTB) is one of 
the causes of ROS. The cellular immune system serves 
as the self-defense mechanism against MTB infection in 
patients with TB. Oxidative antimicrobial response from 
phagocytic cells actively occurs during the phagocytosis 
via activation of NADPH oxidase. NADPH oxidase 
reduces oxygen into free radicals, a process that is known 
as respiratory burst (Voskuil et al., 2011). Elevating ROS 
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level, as well as the provision of anti-tuberculosis drug 
and improvement of the immune system in patients with 
TB will increase the use of endogenous antioxidants to 
neutralize ROS. When the detoxification of endogenous 
antioxidant capacity remains or decrease, it result to 
oxidative stress (Akiibinu et al., 2011). Kaur et al. (2005) 
state that the decrease in antioxidant levels in TB patients 
happens due to an increase of ROS. 
Glutathione (GSH) is one of the antioxidants that 
involved in the regulation of the immune system, acting as 
a major component in the respiratory burst (Seres et al., 
2000), protects lung cells from inflammation, protecting 
cells from the toxicity of ROS and directly acts as 
antimicrobials to boost the immune system and inhibit the 
growth of MTB. It also controls the intracellular growth of 
MTB in macrophages, having antimicrobial activity that 
acts as a carrier of NO, and as an effector molecule in 
cellular immunity to the body's defense against MTB 
infection (Venketaraman et al., 2005; Dayaram et al., 
2006; Connell and Venketaraman, 2009).  
Several studies have reported that the strain of MTB 
is sensitive to the antioxidant glutathione (Venketaraman 
et al., 2005; Dayaram et al., 2006). Glutathione can affect 
cell proliferation, prevent lipid peroxidation of unsaturated 
to neutralize ROS, an important process in the defense 
against bacterial infections MTB (Connell and 
Venketaraman, 2009) . Glutathione synthesis regulated 
through two stages, each catalyzed by different enzymes. 
Phase I is the formation of the γ-glutamylcystein dipeptide 
of glutamic acid and cysteine which catalyzed by the 
enzyme glutamate-cysteine ligase (GCL). Phase II is the 
glutathione synthesis of γ-glutamylcystein and glycine 
which catalyzed by the enzyme glutathione synthetase 
(GSS). The enzymes that synthesize glutathione are 
genetically expressed by the sequence of the genes that 
make up a protein enzyme. Glutamate cysteine ligase 
(GCL) consists of a catalytic subunit encoded by the gene 
modifier GCLC and subunits encoded by GCLM genes. 
Glutamate cysteine ligase catalytic (GCLC) is one of 
the genes that are important for enzyme catalysis, protein 
synthesis, allowing responses and protection against 
oxidative stress (Koide et al., 2003). Polymorphism-
resulted GCL enzyme expression and activity are 
significantly reduced. Moreover, phenotype indicates the 
severity of the disease, such as myocardial infarction, 
cancer, diabetes and HIV / AIDS (Koide et al., 2003; 
Wang et al., 2012). The GCL gene polymorphism and the 
level of glutathione and F2-isoprostanes in the TB patients 
and normal individuals have been describe (Nwanjo and 
Oze, 2007; Yuniastuti et al., 2013), but for the contacts of 
person with infectious TB have never been reported. That 
is why in this study we want to examine the association 
between the polymorphism in the GCLC gene with 
glutathione plasma level and F2-isoprostanes in contacts 
of person with infectious TB. Thus, it is expected that 
transmission of pulmonary TB disease may be recognized 
earlier before going on a broader contagion. 
 
 
 
MATERIALS AND METHOD 
 
Research population 
The population in this study were all contacts of person 
with infectious TB who have TB  patient in their house 
who visited Pulmonary Health Center Society (BBKPM) 
and the Policlinic in Dr. Wahidin Sudirohusodo Hospital, 
Makassar, Indonesia, for treatments. 
 
Research samples 
 
Samples in this study were blood specimen taken from 
contacts of person with infectious TB (approximately 6 
months) who met the inclusion and exclusion criteria and 
willing to participate in this study, proven by signing the 
written informed concent. 
 
Extraction of DNA from Blood 
 
The process of Genomic DNA extraction procedure is 
conducted using the mini kit for blood (Geneaid) with 
several modifications. Total of 200 uL vacucyte blood 
sample in EDTA tubes taken and added in eppendorf 
tube then mixed with 20 uL proteinase K (vortex for 15 
min and incubated at 60 °C for 10 min). At the end 
incubation, 200 uL of ethanol absolute was added and 
vortexed for 10 sec. The sample was transferred into the 
GD column and centrifuged at 16000 ×g for 2 min. The 
supernatan was discarded, 600 uL washing buffer was 
added and centrifuged at 16000 ×g for 30 sec. After 
thorough drying, the GD column was transferred into a 
new eppendorf tube. Next, we added 100 uL of elution 
buffer that has been heated right in the matrix and 
incubated for 5 min. After a centrifugation step at 16000 
×g during 30 sec, the results of DNA elution in eppendorf 
tube are ready for PCR. 
 
GCLM gene amplification  
 
Two oligonucleotide primers were used to amplify a 613 
bp fragment of the GCLC promoter (forward: 5’-
TCGTCCCAAGTCTCACAGTC-3’) (reverse 5’-
CGCCCTCCCCGCTGCTC CTC-3’) (Koide et al., 2003). 
PCR amplification was conducted in 25 L of a reaction 
mixture containing 12.5 uL HotStar MMX, 0.5 uL of each 
primer, 6.5 uL nuclease-free water and 5 uL of extracted 
DNA. The amplification conditions included an initial 
denaturation at   95 °C for 15 min, denaturation at 95 °C 
for 1 min, annealing at 67 °C for 1 min, extention at 72 °C 
for 1 min and final extention at 72 °C for 15 min followed 
by 35 cycles. 
 
RFLP and electrophoresis 
 
The result of PCR product from GCLC gene with 613 bp 
length was cut with the addition of Tsp45I restriction 
enzyme by adding PCR products and then incubated at 
65 °C for 1 h. After incubation, the PCR product is 
qualified for electrophoresis using 2% agarose gel that 
contains ethidium bromide. Further electrophoresis 
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results are observed under UV light. Positive results 
GCLC genes is indicated by the formation of two bands of 
500 bp and 113 bp for C/C allele, 4 bands of 500 bp, 113 
bp, 198 bp and 302 bp for C/T allele, 3 band along 113 bp, 
198 bp and 302 bp for T/T allele (Koide et al., 2003). 
 
Biochemical examination 
 
The Examination of glutathione levels and F2-
isoprostanes was performed using ELISA cusabio kit by 
comparing to the normal levels of glutathione of 1-10 mM 
(Hamilton et al., 2003) and F2-isoprostanes of 10-70 
pg/mL (Montuschi et al., 2004). 
 
Data analysis 
 
The results of GCLC RFLP test are served to compare 
the levels of glutathione (GSH) and F2-isoprostanes levels 
of contacts of persons with infectious TB. The obtained 
data are tested using Chi-square statistical analysis and 
Pearson correlation. 
 
RESULTS 
 
RFLP-PCR of GCLC gene 
 
Amplification of GCLC gene using specific primers shown 
positive results and was detected in the band with a size 
of 613 bp (Figure 1). 
 
Figure 1: The results of electrophoresis of PCR products 
of GCLC genes in samples of contacts with infectious TB. 
 
The results of cutting the DNA using restriction enzymes 
at the Tsp45I 5' GTSAC 3’ site with complementary side 
3' CASTG 5’ using PCR-RFLP showed that: Genotype 
C/C cut DNA segment into two parts consist of Segment 
500 bp and 113 bp. Genotype C/T cut into 4 sections of 
DNA segments consist of segments of 500 bp, 302 bp, 
198 bp and 113 bp. Genotype T/T to cut a segment of 
DNA into 3 parts consisting of segments 302 bp, 198 bp 
and 113 bp (Figure 2).  
In this study, from the total of 71 samples, the 
distribution of GCLC gene polymorphism shown 57 
(80.3%) samples of contacts have C/C allele, 13 (18.3%) 
samples of contacts have C/T allele, and 1 (1.4%) 
samples of contact have T/T allele (Table 1). Chi-Square 
test results showed that there were significant differences 
between genotypes CC, CT and TT with a significance 
value of p = 0.000 (p <0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Results of PCR-RFLP electrophoresis with 
Tsp45I GCLC genes in samples of contacts with 
infectious TB. 
 
Table 1: Distribution of genotype GCLC genes in samples 
of contacts with infectious TB. 
 
Levels of glutathione (GSH) 
 
Based on the results of glutathione level by using ELISA, 
71 samples obtained minimum and maximum GSH levels 
of 0.167 mM/mL and 0.548 mM/mL, respectively. The 
normal level of GSH is 2-8 mM/mL. Chi-square analysis 
results between glutathione levels and GCLC gene 
polymorphism were obtained value p = 0.262 which 
means there is no significant correlation between gene 
polymorphism GCLC to decreased levels of GSH. 
 
Levels F2-isoprostanes 
 
The results of F2-isoprostanes examination using ELISA 
from 71 individuals shown average level of F2-
isoprostanes (616.1 pg/mL) with a minimum and 
maximum value of 72.4 pg/mL and 1343.9 pg/mL, 
respectively. The value of standard deviation is 255.5 with 
normal values of F2-isoprostanes in the blood is 20-80 
pg/mL. 
Chi-square analysis results between levels of F2-
isoprostanes and GCLC gene polymorphism obtained p = 
0.000 (p <0.05), which shown significant differences in the 
distribution of F2-isoprostanes levels with gene 
polymorphism GCLC from contacts of person with 
infectious TB. From the results above, it can be observed 
that the examination of F2-isoprostanes levels are found 
Genotype Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 C/C 57 80.3 80.3 80.3 
C/T 13 18.3 18.3 98.6 
T/T 1 1.4 1.4 100.0 
Total 71 100.0 100.0 
 
500 bp 
 
302 bp 
198 bp 
113 bp 
 
    CC            CT            TT    
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within normal level on 3 people. Meanwhile, we got 68 
people from contacts of person with infectious TB with 
high level of F2-isoprostanes.  
Pearson correlation test between the level of  GCLC 
gene polymorphisms towards the level of F2-isoprostanes 
obtained the Sig. (2-tailed) = 0.630, which means there is 
no significant correlation between gene polymorphism 
GCLC to increased levels of F2-isoprostanes. 
 
DISCUSSION 
 
The host defense against infection of Mycobacterium 
tuberculosis through respiratory burst in macrophage 
generates reactive oxygen species (ROS). Increased 
ROS led to an increase in the use of antioxidants such as 
glutathione to neutralize ROS. If an increase in oxidants 
are higher than a number of antioxidants in the cells,  it 
will result in oxidative stress. These studies demonstrated 
GCLC gene polymorphism at C/T and T/T allele with 
lower percentages compared to the GCLC gene 
polymorphism found in patients with lung disorders 
(Chang et al., 2008; Siedlinski et al., 2008; Yuniastuti et 
al., 2013). This discovery has shown that contacts of 
person with infectious TB is still susceptible to oxidative 
stress. Most of the samples with the history of contact 
with pulmonary TB patients experiencing oxidative stress 
that is characterized by high levels of F2-isoprostanes. 
However, not all oxidative stresses are caused by GCLC 
gene polymorphism that reduces the production of 
glutathione in the body. It may also be caused by several 
factors such as the presence of other infections, low 
intake of vitamins C and E, poor lifestyle such as heavy 
cigarette consumption, and also the presence of chronic 
diseases (Nwanjo and Oze, 2007; Siedlinski et al., 2008).  
GCLC gene is a gene cluster in the catalytic 
formation of glutathione (an antioxidant cellular). 
Glutathione is naturally present in the human body cells, 
has a dominant role in the regulation of the main cells in 
the intracellular redox reaction, and protect the body from 
oxidative stress by binding with free radicals (Koide et al., 
2003). Various reports have reported that the levels of 
cellular antioxidant glutathione are significantly decreased 
in TB patients as well as other lung diseases (Nwanjo and 
Oze, 2007; Venketaraman et al., 2008; Akiibinu et al., 
2011; Yuniastuti et al., 2013).   
Glutathione levels that were obtained from samples 
had low levels compared to normal values of 1-10 mM 
GSH/mL. However, these levels are still higher compared 
to previous studies in patients with active TB before 
taking the anti-tuberculosis drug in which they shown an 
average level of glutathione (Nwanjo and Oze, 2007; 
Yuniastuti et al., 2013). This result indicates the different 
levels of glutathione between active TB and contacts of 
person with infectious TB due to the difference in the 
number of germs, levels of infection, and the imbalance 
between oxidants and antioxidants in the body. 
Glutathione in TB patients are widely used to neutralize 
germs, free radical and oxidative stress response. 
Furthermore, the presence of glutathione can be seen 
with the increased levels of F2-isoprostanes 
(Venketaraman et al., 2005). In addition, several 
compounds that can induce oxidative stress, such as 
TGF-β1, H2O2, menadione, cigarette substances, and 
okadaic acid has been displayed to decrease gene 
expression of GCL and induce the early depletion of GSH 
(Jardine et al., 2002). 
F2-isoprostanes is one of the metabolites of 
arachidonic acid oxidation by free radicals plasma 
membrane that resembles prostatglandin. F2-isoprostanes 
can be used as a marker of oxidative stress because it is 
also stable. Several studies have reported that the use 
isoprostane as an indicator of oxidative stress in human 
disease, especially in lung disorders (Morrow et al., 1995; 
Repine et al., 1997). Isoprostane concentrations have 
shown to escalate in individuals with chronic obstructive 
pulmonary disease (Repine et al., 1997; Pratico et al., 
1998). 
Based on the results of the examination F2-
isoprostanes of individual who had contacted infection TB 
shown the high levels of F2-isoprostanes. This data is 
consistent with the results of Glutathione (GSH) which 
shown low levels of cellular antioxidant that is 
accompanied by high levels of cellular oxidants. However, 
this study found no correlation between GCLC gene 
polymorphism in TB contacts against the high levels of 
glutathione (cellular antioxidant) and low levels of F2-
isoprostanes (cellular oxidants). This result is very 
different from the results in several cases of TB patients 
(Yuniastuti et al., 2013). Other studies have shown the 
significant differences in the high levels of oxidants in TB 
patients compared to the population of controls, and there 
is a significant difference to the decreased levels of 
antioxidants in TB patients compared with the population 
of controls (Akibiinu et al., 2011). Currently, there are 
limited works of literature reporting GCLC gene 
polymorphism in pulmonary TB contacts. Therefore, 
further research needs to be conducted to discover other 
markers as an early detection of pulmonary TB contacts 
that is vulnerable to oxidative stress.  
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